Logo image of HYAC

HAYMAKER ACQUISITION CORP 4 (HYAC) Stock Fundamental Analysis

NYSE:HYAC - New York Stock Exchange, Inc. - KYG4375F1081 - Common Stock - Currency: USD

11.11  -0.03 (-0.27%)

Fundamental Rating

1

Overall HYAC gets a fundamental rating of 1 out of 10. We evaluated HYAC against 0 industry peers in the Unkown industry. HYAC has a bad profitability rating. Also its financial health evaluation is rather negative. HYAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HYAC had positive earnings in the past year.
HYAC had a negative operating cash flow in the past year.
In multiple years HYAC reported negative net income over the last 5 years.
In the past 5 years HYAC always reported negative operating cash flow.
HYAC Yearly Net Income VS EBIT VS OCF VS FCFHYAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 4.25%
ROE 4.42%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYAC Yearly ROA, ROE, ROICHYAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HYAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYAC Yearly Profit, Operating, Gross MarginsHYAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for HYAC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, HYAC has less shares outstanding
HYAC has a worse debt/assets ratio than last year.
HYAC Yearly Shares OutstandingHYAC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2023 2024 10M 20M 30M 40M
HYAC Yearly Total Debt VS Total AssetsHYAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2023 2024 100M 200M 300M 400M

2.2 Solvency

HYAC has an Altman-Z score of 20.38. This indicates that HYAC is financially healthy and has little risk of bankruptcy at the moment.
HYAC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.38
ROIC/WACCN/A
WACCN/A
HYAC Yearly LT Debt VS Equity VS FCFHYAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.14 indicates that HYAC may have some problems paying its short term obligations.
A Quick Ratio of 0.14 indicates that HYAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
HYAC Yearly Current Assets VS Current LiabilitesHYAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2023 2024 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

HYAC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.19%.
Measured over the past years, HYAC shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.28% on average per year.
EPS 1Y (TTM)-4.19%
EPS 3Y10.73%
EPS 5Y43.28%
EPS Q2Q%-20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.03 indicates a quite expensive valuation of HYAC.
HYAC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.03
Fwd PE N/A
HYAC Price Earnings VS Forward Price EarningsHYAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYAC Per share dataHYAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HYAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAYMAKER ACQUISITION CORP 4

NYSE:HYAC (7/21/2025, 10:33:52 AM)

11.11

-0.03 (-0.27%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-15 2025-05-15
Earnings (Next)N/A N/A
Inst Owners95.37%
Inst Owner Change-0.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap328.30M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.03
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.37
EY3.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS8.23
TBVpS8.23
PEG (NY)N/A
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 4.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 20.38
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.19%
EPS 3Y10.73%
EPS 5Y43.28%
EPS Q2Q%-20%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.15%
OCF growth 3YN/A
OCF growth 5YN/A